Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with CancerDavid J. Pinato, Javier Marco‐Hernández, Alberto Zambelli et al.|Cancer Discovery|2020Cited by 183
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European studyDavid J. Pinato, Yien Ning Sophia Wong, Lorenza Scotti et al.|European Journal of Cancer|2021Cited by 51
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World SettingRamona Erber, Arndt Hartmann, Miriam Angeloni et al.|International Journal of Molecular Sciences|2022Cited by 13
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registryLaia Garrigós, Maria Belen Delany, Sònia Pernas et al.|Therapeutic Advances in Medical Oncology|2021Cited by 7
Early prediction of endocrine responsiveness in ER+/HER2 negative MBC: Pilot study with 18F-fluoroestradiol (18F-FES) CT/PET.Alessandra Gennari, Nadia Harbeck, Étienne Brain et al.|Journal of Clinical Oncology|2023Cited by 2